Summit Therapeutics (SMMT) Invested Capital (2019)
Summit Therapeutics (SMMT) posted Invested Capital of $10.3 million for Q4 2019, down 7.89% on a QoQ basis from $11.2 million in Q1 2019.
Summit Therapeutics (SMMT) Invested Capital (2019) Analysis & Trends
Summit Therapeutics' Invested Capital history runs 1 years deep, the most recent figure standing at $10.3 million for Q4 2019.
- Quarterly Invested Capital changed N/A year-over-year to $10.3 million in Q4 2019, while the trailing twelve-month figure through Sep 2020 was $10.3 million (down 7.89% YoY) and the FY2019 annual result came in at $10.3 million, changed N/A from the prior year.
- Invested Capital was $10.3 million for Q4 2019 at Summit Therapeutics, down from $11.2 million in the prior quarter.
- Across five years, Invested Capital topped out at $11.2 million in Q1 2019 and bottomed at $10.3 million in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | 110.96 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 116.14 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Summit Therapeutics | 10.60 Bn | 10.00 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 10.31 Mn |
| Jan 31, 2019 | 11.19 Mn |